glutathione therapy for parkinson& 39 Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024 Revamping Parkinson's disease therapy using
Description
The assay based on the reaction of GSH with 5,5-dithio-bis-2-nitrobenzoic acid (DTNB) in the presence of glutathione reductase, was performed according to the protocol 56 and measured with a TECAN plate reader at 412 nm
Keep separate for best results
Sierra S, Lara-Villoslada F, Olivares M, Jimnez J, Boza J, Xaus J
3 (33), CD004655
K.ParkH
however, unlike H 2 O 2 exposure, BSO had no significant effect on GSSG levels (Fig
